Melanoma Risk Declines With Self-Exams Plus Doctor Visit

This article originally appeared here.
Share this content:
Melanoma Risk Declines With Self-Exams Plus Doctor Visit
Melanoma Risk Declines With Self-Exams Plus Doctor Visit

(HealthDay News) -- Risk of deeper melanomas is reduced with self-examination of the skin one to 11 times a year, according to a study published online Aug. 16 in the British Journal of Dermatology.

Linda J. Titus, Ph.D., from the Dartmouth-Hitchcock Medical Center in Lebanon, N.H., and colleagues analyzed data from a population-based case-control study (423 cases and 678 controls) to assess recent skin self-examination in relation to self-detection, melanoma risk, and tumor depth.

The researchers found that skin self-examination conducted one to 11 times during a recent year was associated with a possible decrease in melanoma risk (odds ratio [OR], 0.74). For those who conducted skin self-examination and saw a doctor, the melanoma risk was significantly decreased (OR, 0.54). Among those patients with melanoma, those who examined their skin were twice as likely to self-detect the melanoma (OR, 2.23), but self-detection was not associated with shallower tumors. For those who conducted skin self-examination one to 11 times during a recent year, tumor depth was significantly reduced (OR, 0.39), but was not influenced by seeing a doctor or by conducting skin self-examination combined with seeing a doctor.

"Risk of a deeper tumor and possibly risk of melanoma were reduced by skin self-examination one to 11 times annually," the authors write.

Abstract

Full Text (subscription or payment may be required)

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs